NCT03119116 - Use of Direct Oral Anticoagulants in UK | Biotech Hunter

Enrollment

31,336

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

October 16, 2017

Study Completion Date

April 16, 2019

Conditions

Stroke

Interventions

DRUG

Rivaroxaban (Xarelto, BAY59-7939)

Oral direct factor Xa inhibitors, 15mg and 20mg tablets QD

DRUG

Dabigatran

Oral direct thrombin inhibitors, 75mg and 150mg capsules BID

DRUG

Apixaban

Oral direct factor Xa inhibitors, 2.5mg and 5 mg tablets BID

Trial Locations (1)

Many Locations, Multiple Locations